-
CONSORT and SPIRIT update 2025
📢 Attention all medical writers, publication professionals and clinical researchers! 📢 You have been waiting for 15 years, and now it’s there! 🏆 Yes, you have guessed right – we are talking about the CONSORT 2025 statement simultaneously published yesterday in The BMJ, JAMA, The Lancet, Nature Medicine and PLOS Medicine. ⭐ The Consolidated Standards…
-
When does information become an insight?
‘Medical insights’ is a broad term comprising any type of information obtained from the external environment. The main value of medical insights is their relevance to the company’s medical strategy and overarching disease area strategy. Traditionally, pharmaceutical companies used to collect insights in a structured, targeted approach, via conducting advisory boards with physicians or collecting…
-
Medical Education: Speaker selection
After the content, your speaker panel is probably the most important element of a medical education event (for example, a symposium or a webinar). 📢 So who are the best speakers and how do we find them? Are there foolproof criteria we can use to ensure an all-star speaker line-up? 📢 The short answer is…
-
Medical Education: Manels
How frequently do we see ‘manels’ (scientific panels made up exclusively from men) in the field of biomedical sciences? Considering that the gender distribution in entry and mid-level positions is about 50:50, it’s shocking to see that in 2020s, male-only or male-dominated line-ups are so widespread. We looked at the speaker panels of the industry-sponsored…
-
Reporting on race and ethnicity
One of the recent hot topics in medical research is the role of race and ethnicity in health disparities. If you look on PubMed, you will find tons of literature describing how race and ethnicity affect:🫀 life expectancy⚕️ access to quality medical care💉 healthcare hesitancy🏥 clinical trial recruitmentMany pharmaceutical companies now invest in research into…
